NSEOutcome of Board Meeting1d ago · 23 Jul 2026, 03:48 pm
Outcome of Board Meeting
Thyrocare Technologies Limited · THYROCARE
✦ AI SummaryResults
Thyrocare Technologies Limited has announced the outcome of its board meeting, which included the approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review report. The board also approved the re-appointment of Ernst & Young LLP as the internal auditor for the financial year 2026-27.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Outcome of the Board Meeting held on July 23, 2026
Attachments (1)
📄pdf
Download →
THYROCARE_23072026154820_Outcome.pdf
View document text
July 23, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza Phiroze Jeejeebhoy Towers
B(SaYnMdrBaO KLu:r TlaH CYoRmOpCleAxR, E ) D(SaClaRlI SPt rCeOeDt, E: 539871)
Bandra (E), Mumbai - 400051 Mumbai- 400001
Subject: Outcome of the Board Meeting held on Thursday, July 23, 2026
1) Unaudited Standalone and Consolidated Financial Results along with the Limited
Review Report for the quarter ended June 30, 2026; and
2D)ear RSeir-A/Mppaodianmtm, ent of Internal Auditor for the Financial Year 2026-27
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities
(“SEBI Listing Regulations
and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
Board ., Thursday, July 23, 2026,
2015 ”), we wish to inform you that the Board of Directors of the
Company (“ ”), at its meeting held today, i.e inter alia,
considered and approved the following matters:
1. Unaudited Standalone and Consolidated Financial Results along with the Limited
Review Report for the quarter ended June 30, 2026
The Board has approved the Unaudited Standalone and Consolidated Financial Results of
the Company along with the Limited Review Report for the quarter ended June 30, 2026.
Pursuant to Regulation 33(3) of the SEBI Listing Regulations, copies of the Standalone and
Consolidated unaudited financial reAsnunltesx fuorr eth Ae quarter ended June 30, 2026, along with
the Limited Review Reports on the said financial results issued by the Statutory Auditors
2. Rofe t-hAep Cpoominptamneyn atr eo fa Itntatcehrenda la sA aund itor for the Ftion athnicsi laelt tYeera.r 2026-27
M/s. Ernst & Young LLP, Chartered Accountants
Based on the recommendation of the Audit Committee, the Board has approved the re-
appointment of , as Internal Auditors
of the Company for the Financial Year 2026-27.
Disclosure of information pursuaAnnt ntoe xRuergeu lBat ion 30 of SEBI Listing Regulations, read with
SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
January 30, 2026, is annexed as to this letter.
The above disclosures are also being made available on the website of the Company at
https://investor.thyrocare.com.
The Board Meeting commenced at 2:45 P.M. and concluded at 03:35 P.M.
This is for your information and records.
Thyrocare Technologies Limited,
Yours Faithfully,
Brijesh Kumar
Company Secretary and Compliance Officer
Encl. A/a
Annexure-A
Annexure-B
Disclosure of information pursuant to Regulation 30 of SEBI Listing Regulations read
with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026
dated January 30, 2026
Re-appointment of Internal Auditor of the Company
1. Name of Internal Auditor M/s. Ernst & Young LLP, Chartered
Accountants (“EY”)
2. Reason for change viz. appointment, re- Re-appointment
appointment, resignation, removal, death
or otherwise
3. Date of appointment/re-appointment/ Date of Re-appointment: July 23, 2026
cessation (as applicable) & term of Term of Appointment: For the Financial
appointment/re-appointment; year 2026-27
4. Brief Profile (in case of appointment) EY India is a globally connected,
m"Suhlatpidinisgc itphlein faurtyu re pwriothfe csosniofnidaeln ces"ervices
organization driven by the purpose of
for its
clients, people and communities.
Through its four service lines - Assurance,
Consulting, Tax, and Strategy and
Transactions and its deep sector
knowledge, EY India helps its clients
capitalize on new opportunities, assess and
manage risks, deliver responsible growth,
fulfil regulatory requirements, keep
investors informed, and meet stakeholder
needs.
EY India has a workforce of over 48,000
professionals with a presence across 16
cities in India, including Ahmedabad,
Bengaluru, Bhubaneswar, Chandigarh,
Chennai, Gandhinagar, Hyderabad, Jaipur,
Kochi, Kolkata, Mumbai, NCR (New Delhi,
Gurugram and Noida), Pune and Vadodara.
EY India's Risk Consulting services assist
clients in transforming their risk and
control functions while building confidence
among stakeholders.
5. Disclosure of relationships between Not Applicable
directors (in case of appointment of a
director)